Inactive Instrument

Karex Bhd Share Price Other OTC

Equities

Personal Products

Financials

Sales 2024 * 512M 109M 9.05B Sales 2025 * 560M 119M 9.9B Capitalization 848M 180M 14.99B
Net income 2024 * 25M 5.3M 442M Net income 2025 * 46M 9.76M 813M EV / Sales 2024 * 1.66 x
Net cash position 2024 * - 0 0 Net cash position 2025 * - 0 0 EV / Sales 2025 * 1.51 x
P/E ratio 2024 *
33.5 x
P/E ratio 2025 *
18.3 x
Employees -
Yield 2024 *
1.24%
Yield 2025 *
1.37%
Free-Float 39.47%
More Fundamentals * Assessed data
Dynamic Chart
Managers TitleAgeSince
Chief Executive Officer 46 29/13/29
Director of Finance/CFO 53 01/13/01
Chief Tech/Sci/R&D Officer 69 27/12/27
Members of the board TitleAgeSince
Director/Board Member 62 17/23/17
Director/Board Member 67 27/20/27
Chief Executive Officer 46 29/13/29
More insiders
Karex Berhad is a Malaysia-based investment holding company. The Company has three segments. Sexual Wellness segment is engaged in the sale of condoms, personal lubricants and sex toys. Medical segment is engaged in the sale of catheters, probe covers, human immunodeficiency virus (HIV) and pregnancy test kits, and other medical related products. Other segment is engaged in the sale of products not related to sexual wellness and medical. Its subsidiaries, including Hevea Medical Sdn. Bhd., Innolatex Sdn. Bhd., Innolatex (Thailand) Limited, Karex Industries Sdn. Bhd. and Medical-Latex (Dua) Sdn. Bhd., are engaged in the manufacturing and selling of condoms, rubber products, personal lubricants and others. Its subsidiary, Karex Marketing Sdn. Bhd., is involved in manufacturing and selling hand sanitizers, condoms, personal lubricants and others. Its subsidiaries, Karex Global Limited, Karex Holdings Sdn. Bhd., Karex International Sdn. Bhd., are engaged in investment holding activity.
More about the company